IL97424A - Use of guanidine for the preparation of a medicinal product with anti-neuropfed Y activity - Google Patents

Use of guanidine for the preparation of a medicinal product with anti-neuropfed Y activity

Info

Publication number
IL97424A
IL97424A IL9742491A IL9742491A IL97424A IL 97424 A IL97424 A IL 97424A IL 9742491 A IL9742491 A IL 9742491A IL 9742491 A IL9742491 A IL 9742491A IL 97424 A IL97424 A IL 97424A
Authority
IL
Israel
Prior art keywords
pyridin
propyl
guanidine
ethyl
bromo
Prior art date
Application number
IL9742491A
Other languages
English (en)
Hebrew (he)
Other versions
IL97424A0 (en
Original Assignee
Heumann Pharma Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heumann Pharma Gmbh & Co filed Critical Heumann Pharma Gmbh & Co
Publication of IL97424A0 publication Critical patent/IL97424A0/xx
Publication of IL97424A publication Critical patent/IL97424A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
IL9742491A 1990-03-30 1991-03-04 Use of guanidine for the preparation of a medicinal product with anti-neuropfed Y activity IL97424A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90106200A EP0448765B1 (de) 1990-03-30 1990-03-30 Verwendung von Guanidinderivaten zur Herstellung eines Arzneimittels mit NPY-antagonistischer Wirkung

Publications (2)

Publication Number Publication Date
IL97424A0 IL97424A0 (en) 1992-06-21
IL97424A true IL97424A (en) 1995-05-26

Family

ID=8203843

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9742491A IL97424A (en) 1990-03-30 1991-03-04 Use of guanidine for the preparation of a medicinal product with anti-neuropfed Y activity

Country Status (14)

Country Link
EP (1) EP0448765B1 (es)
JP (1) JPH0789939A (es)
KR (1) KR910016329A (es)
AT (1) ATE109979T1 (es)
AU (1) AU637882B2 (es)
CA (1) CA2037433A1 (es)
DE (1) DE59006842D1 (es)
DK (1) DK0448765T3 (es)
ES (1) ES2058651T3 (es)
HU (1) HU207945B (es)
IE (1) IE65252B1 (es)
IL (1) IL97424A (es)
PT (1) PT97138A (es)
ZA (1) ZA911471B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2126212A1 (en) * 1991-12-19 1993-07-08 Albert Tseng A novel molecule which inhibits neuropeptide tyrosine biological function
US5516653A (en) * 1993-12-28 1996-05-14 Synaptic Pharmaceutical Corporation DNA encoding a human neuropeptide Y/peptide YY/pancreatic polypeptide receptor (Y4) and uses thereof
US5545549A (en) * 1994-02-03 1996-08-13 Synaptic Pharmaceutical Corporation DNA encoding a human neuropeptide Y/peptide YY (Y2) receptor and uses thereof
US5602024A (en) 1994-12-02 1997-02-11 Synaptic Pharmaceutical Corporation DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) and uses thereof
US5989920A (en) 1994-12-02 1999-11-23 Synaptic Pharmaceutical Corporation Methods of modifying feeding behavior compounds useful in such methods and DNA encoding a hypothalmic atypical neuropeptide Y/peptide YY receptor Y5
WO1997020822A1 (en) * 1995-12-01 1997-06-12 Novartis Ag Quinazolin-2,4-diazirines as npy receptor antagonist
WO1997020823A2 (en) * 1995-12-01 1997-06-12 Novartis Ag 2-amino quinazoline derivatives as npy receptor antagonists
JP2001525793A (ja) * 1996-05-14 2001-12-11 ノボ ノルディスク アクティーゼルスカブ ソマトスタチンの作動因子及び拮抗因子
DK0984778T3 (da) * 1996-08-23 2002-09-16 Agouron Pharma Neuropeptid-Y-ligander
FR2754709B1 (fr) 1996-10-23 1999-03-05 Sanofi Sa Composition cosmetique contenant un antagoniste des recepteurs du neuropeptide gamma et alpha 2 antagonistes susceptibles d'etre incorpores dans une telle composition
ZA979701B (en) * 1996-10-31 1998-05-21 Novo Nordisk As Novo Nordisk A Constrained somatostatin agonists and antagonists.Constrained somatostatin agonists and antagonists.
WO1998035944A1 (en) * 1997-02-14 1998-08-20 Bayer Corporation Amides as npy5 receptor antagonists
US6048900A (en) 1998-02-13 2000-04-11 Bayer Corporation Amide derivatives and methods for using the same as selective neuropeptide Y receptor antagonists
AU6144098A (en) * 1997-02-14 1998-09-08 Bayer Corporation Amide derivatives as selective neuropeptide y receptor antagonists
US6245817B1 (en) 1997-02-14 2001-06-12 Bayer Corporation NPY5 receptor antagonists and methods for using same
US6713265B1 (en) 1997-06-04 2004-03-30 Synaptic Pharmaceutical Corporation Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
AU744297B2 (en) 1997-07-03 2002-02-21 Neurogen Corporation Certain diarylimidazole derivatives; a new class of NPY specific ligands
ES2161594B1 (es) * 1998-12-17 2003-04-01 Servier Lab Nuevos derivados de la hidrazida, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
AU2935200A (en) 1999-04-30 2000-11-17 Pfizer Products Inc. Compounds for the treatment of obesity
US6518287B2 (en) 2000-09-20 2003-02-11 Schering Corporation Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
AU2001291040A1 (en) 2000-09-20 2002-04-02 Schering Corporation Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
EP1318994B1 (en) 2000-09-20 2008-02-27 Schering Corporation Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
CA2422729A1 (en) 2000-09-20 2002-06-06 Schering Corporation Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3579000D1 (de) * 1985-04-02 1990-09-06 Heumann Pharma Gmbh & Co Imidazolylalkylguanidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
DE3631334A1 (de) * 1986-09-15 1988-03-17 Heumann Pharma Gmbh & Co Neue imidazolylguanidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
DE59006842D1 (de) 1994-09-22
HU910979D0 (en) 1991-10-28
DK0448765T3 (da) 1994-09-19
EP0448765B1 (de) 1994-08-17
KR910016329A (ko) 1991-11-05
JPH0789939A (ja) 1995-04-04
IE65252B1 (en) 1995-10-18
HU207945B (en) 1993-07-28
AU637882B2 (en) 1993-06-10
PT97138A (pt) 1991-11-29
IE910995A1 (en) 1991-10-09
AU7206891A (en) 1991-10-03
HUT57044A (en) 1991-11-28
ES2058651T3 (es) 1994-11-01
ATE109979T1 (de) 1994-09-15
EP0448765A1 (de) 1991-10-02
CA2037433A1 (en) 1991-10-01
ZA911471B (en) 1991-11-27
IL97424A0 (en) 1992-06-21

Similar Documents

Publication Publication Date Title
IL97424A (en) Use of guanidine for the preparation of a medicinal product with anti-neuropfed Y activity
AU2005297966B2 (en) Amorphous object of cinnamide compound
CS244423B2 (en) Method of substituted 1,2-diaminocyclobuten-3,4-dions production
KR960009570B1 (ko) 이미다졸린 유도체 및 그의 제조방법
JP2001502712A (ja) 束縛されたソマトスタチン・アゴニスト及びアンタゴニスト
US4912119A (en) Imidazolylguanidine derivatives and compositions containing these compounds
US9090624B2 (en) Aromatic bycyclic derivatives as CXCR4 receptor modulators
FI70580C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara n-(4-/i 3-staellning substituerad pyridyl/-piperatzinyl)alk ylazaspirodecandioner
SU1694064A3 (ru) Способ получени N-/бициклических гетероцикло)-4-пиперидинаминов, фармацевтически приемлемой соли присоединени кислоты или стереохимически возможной изомерной ее формы
KR930011491B1 (ko) 이미다졸릴 알킬 구아니딘 유도체의 제조방법
EP0441226A1 (en) (cyanomethyl)pyridines useful as PAF antagonists
WO2004058713A1 (en) Differential tumor cytotoxocity compounds and compositions
US5212187A (en) Pyridyl alkylamine compounds which are useful against histamine h1 and h2 receptors
JPS63270678A (ja) 新規含窒素化合物
KR100248643B1 (ko) 아릴 및 헤테로아릴 알콕시나프탈렌 유도체
EP0105702B1 (en) Dioxocyclobutene compounds
JPS62252780A (ja) 新規なインデノチアゾ−ル誘導体及びその製造法
KR100547506B1 (ko) 테트라졸유도체
EP0775139A1 (en) Imidazopyridine derivatives as dual histamine (h1) and platelet activating factor (paf) antagonists
KR880002209B1 (ko) 치환된 3,4-디아미노-1,2,5-티아디아졸류 및 그의 제조방법
US4948802A (en) Guanidine carboxylic acid esters and pharmaceutical preparations containing these compounds
RU2143429C1 (ru) ПРОИЗВОДНЫЕ 6-(2-ИМИДАЗОЛИНИЛАМИНО)ХИНОЛИНА И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ИХ ОСНОВЕ, ОБЛАДАЮЩАЯ АНТАГОНИСТИЧЕСКОЙ АКТИВНОСТЬЮ В ОТНОШЕНИИ α--2-АДРЕНОРЕЦЕПТОРОВ
US4772704A (en) 2,5-disubstituted-4(3H)-pyrimidones having histamine H2 -receptor antagonist activity
US4590192A (en) Benzisothiazoles, their pharmaceutical compositions, and method of use

Legal Events

Date Code Title Description
RH Patent void